Accuracy of determination of doubling time in lung cancer

Por Mattson, K., Salmo, M., Holsti, L. R.
Publicado em 1980

Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma.

Por Björkqvist, A. M., Tammilehto, L., Anttila, S., Mattson, K., Knuutila, S.
Publicado em 1997

Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.

Por Tiainen, M., Tammilehto, L., Rautonen, J., Tuomi, T., Mattson, K., Knuutila, S.
Publicado em 1989

High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma

Por Halme, M, Knuuttila, A, Vehmas, T, Tammilehto, L, Mäntylä, M, Salo, J, Mattson, K
Publicado em 1999

High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines.

Por Ungar, S., Van de Meeren, A., Tammilehto, L., Linnainmaa, K., Mattson, K., Gerwin, B. I.
Publicado em 1996

Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung.

Por Björkqvist, A. M., Tammilehto, L., Nordling, S., Nurminen, M., Anttila, S., Mattson, K., Knuutila, S.
Publicado em 1998

Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis

Por Björkqvist, A-M, Wolf, M, Nordling, S, Tammilehto, L, Knuuttila, A, Kere, J, Mattson, K, Knuutila, S
Publicado em 1999

Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer

Por Scagliotti, G V, Szczesna, A, Ramlau, R, Cardenal, F, Mattson, K, Van Zandwijk, N, Price, A, Lebeau, B, Debus, J, Manegold, C
Publicado em 2006